Frequently Asked Questions
South Africa is the dominating region in the Middle East and Africa Aesthetic Dermatology Market.
The Middle East and Africa Aesthetic Dermatology Market will grow 7.9% during the forecast period.
Increase in aesthetic expenditure & Rise in preference for minimally invasive and non-invasive procedures are the growth drivers of the Middle East and Africa Aesthetic Dermatology Market.
The product type, surgery type, treatment type, application, gender, end user and distribution channel are the factors on which the Middle East and Africa Aesthetic Dermatology Market research is based.
Major companies in the Middle East and Africa Aesthetic Dermatology Market are AbbVie Inc. (U.S.), Henry Schein, Inc. (U.S.), Merz Pharma (Germany), Cutera (U.S.), Cynosure. Inc. (A Subsidiary of Hologic, Inc.) (U.S.), Candela Medical (U.S.), Bausch Health Companies Inc. (Canada), Evolus, Inc. (U.S.), Medytox (South Korea), LUTRONIC (South Korea), HUGEL, Inc. (South Korea), El. En. S.p.A. (Italy), Hoahai Biological Technology (China), REVANCE THERAPEUTICS (U.S.), Lumenis Be Ltd. (Israel), Venus Concept (Canada), Alma Lasers (Israel), Fotona (Slovenia), Aesthetic Biomedical (U.S.), ThermiGen, LLC. (U.S.), R2 TECHNOLOGIES, INC. (A Subsidiary of INNOVATE Corp.) (U.S.), Sensus Healthcare, Inc. (U.S.), Aesthetic Technology Limited (U.K.), DELEO (France), Biotech Italia Srl (France), Medency (Italy), Aerolase Corp. (U.S.), Sciton (U.S.), Image Derm, Inc. (U.S.) and PhotoMedex (U.S.).
